Document Detail

Erythromycin improves gastric emptying half-time in adult cystic fibrosis patients with gastroparesis.
MedLine Citation:
PMID:  19269261     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Gastrointestinal manifestations are frequently encountered in cystic fibrosis patients. Gastroparesis evidenced by a variety of diagnostic methods has been described in patients with cystic fibrosis, predominantly in children and in individuals with advanced lung disease. The presence of gastroparesis in adult patients with different degrees of lung involvement and its response to the acute and chronic administration of macrolides have not been reported. METHODS: Using the University of Florida Cystic Fibrosis database we identified symptomatic patients who had gastroparesis confirmed by a prolonged half-time during gastric emptying scintigraphy. RESULTS: Of 86 cystic fibrosis patients, periodically followed in our institution, we found five who had classical symptoms and prolonged gastric emptying half-time. Age 25.2+/-8 years, 80% females, BMI 22+/-9 kg/m(2), HbA1c 5.8+/-0.6 g/dl, FEV1 53.2+/-15% of predicted. Gastric emptying half-time was 191.4+/-91.4 min (range 100-300 min) and decreased to 12.2+/-6 min (range 5-20 min) after IV administration of erythromycin (p=0.043). Patients were followed up for 3+/-2.1 years. All patients but one, who was taking opiods, had good clinical response to PO macrolides. CONCLUSIONS: Gastroparesis occurs in patients with cystic fibrosis, even in patients with relatively preserved lung function and in those without cystic-fibrosis related diabetes. Macrolides may be an effective therapy in cystic fibrosis patients with gastroparesis when administered acutely or chronically.
Adriano R Tonelli; Walter E Drane; Dennis P Collins; Wanda Nichols; Veena B Antony; Eric L Olson
Publication Detail:
Type:  Journal Article     Date:  2009-03-09
Journal Detail:
Title:  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society     Volume:  8     ISSN:  1873-5010     ISO Abbreviation:  J. Cyst. Fibros.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-04     Completed Date:  2009-07-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101128966     Medline TA:  J Cyst Fibros     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  193-7     Citation Subset:  IM    
Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, Florida, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cystic Fibrosis / complications*,  radionuclide imaging
Erythromycin / administration & dosage*
Gastric Emptying / drug effects*
Gastrointestinal Agents / administration & dosage*
Gastroparesis / complications,  drug therapy*,  radionuclide imaging
Retrospective Studies
Technetium / diagnostic use
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Gastrointestinal Agents; 114-07-8/Erythromycin; 7440-26-8/Technetium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  DNA-damage response in the basidiomycete fungus Ustilago maydis relies in a sole Chk1-like kinase.
Next Document:  Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection...